Scarica l'app Stockscreener
8.10
0.25%
-0.00
Precedente Chiudi:
$8.10
Aprire:
$8.1
Volume 24 ore:
69,060
Relative Volume:
0.04
Capitalizzazione di mercato:
$6.01M
Reddito:
-
Utile/perdita netta:
$-8.82M
Rapporto P/E:
-0.0117
EPS:
-691.4213
Flusso di cassa netto:
$-8.08M
1 W Prestazione:
+133.76%
1M Prestazione:
+134.20%
6M Prestazione:
+36.49%
1 anno Prestazione:
-94.95%
Intervallo 1D:
$7.82
$8.44
Intervallo di 1 settimana:
$6.60
$11.96
Portata 52W:
$2.90
$170.62
Endra Life Sciences Inc Stock (NDRA) Company Profile
Nome
Endra Life Sciences Inc
Settore
Industria
Telefono
734-335-0468
Indirizzo
3600 GREEN COURT, ANN ARBOR, MI
Confronta NDRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
8.14 | 2.55M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
426.95 | 158.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.08 | 142.87B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
534.47 | 43.87B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.63 | 33.87B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.28 | 28.10B | 15.50B | 1.33B | 2.16B | 7.34 |
Endra Life Sciences Inc Borsa (NDRA) Ultime notizie
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Endra Life Sciences Plunges 13.46% Post Reverse Split - AInvest
NDRA SEC FilingsEndra Life Sciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Gold Falls 1%; ProKidney Shares Spike Higher - Benzinga
MAG 7 Undercard: $5 Stocks to Watch – NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside - FinancialContent
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday - inkl
Endra Life Sciences shares surge 136.62% intraday after announcing a new patent and strategic focus on GLP-1 drug trials. - AInvest
ENDRA’s TAEUS Advancement: A New Era in Liver Imaging? - timothysykes.com
US Stocks Mixed; Small Business Sentiment Falls In June - Benzinga
Endra’s Recent Surge: What’s Fueling the Rise? - StocksToTrade
Endra Life Sciences Soars 144.14% on Investor Interest - AInvest
Endra Life Sciences Soars 86.87% on Market Optimism - AInvest
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - inkl
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - inkl
NDRA Director Granted 5,384 RSUs in Latest Form 4 Filing - Stock Titan
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancem - GuruFocus
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard | NDRA Stock News - GuruFocus
ENDRA's Revolutionary Liver Imaging Technology Achieves Major Breakthrough in 100+ Patient Study - Stock Titan
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ENDRA Life Sciences Unveils New Business Strategy - TipRanks
Wall Street Zen Upgrades ENDRA Life Sciences (NASDAQ:NDRA) to Hold - Defense World
Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
ENDRA Life Sciences Faces Nasdaq Compliance Challenge - TipRanks
ENDRA Life Sciences: Strategic Shift and Financial Update - TipRanks
ENDRA Life Sciences Provides a Business Update and Reports First - GuruFocus
ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus
ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks
ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan
ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.41%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):